Prospective belgian study of neurodegenerative and vascular dementia: APOE genotype effects

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 8, 2003, Pages 1148-1151

  Engelborghs, S ^a   Dermaut, B ^b   Goeman, J ^a   Saerens, J ^a   Marien P ^a   Pickut, B A ^a   Van Den Broeck, M ^b   Serneels, S ^b   Cruts, M ^b   Van Broeckhoven, C ^b   De Deyn, P P ^a,c,d  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BELGIUM; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BELGIUM; DEMENTIA; DEMENTIA, VASCULAR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PROSPECTIVE STUDIES; REFERENCE VALUES;

EID: 0041704541     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.8.1148     Document Type: Article

References (22)

1. Van Duijn C, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-8.
2. Growdon JH. Apolipoprotein E and Alzheimer disease. Arch Neurol 1998;55:1053-4.
3. Burlinson S, Burns A, Mann D, et al. Effect of apolipoprotein E status on clinical features of dementia. Int J Geriatr Psychiatry 1998;13:177-85.
4. Folstein M, Folstein S, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-96.
5. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotyopes from a population-based incidence study: the Rotterdam Study. Arch Neurol 1998;55:964-8.
6. Terwilliger J, Ott J. Handbook of human genetic linkage. Baltimore: Johns Hopkins University Press, 1994.
7. Feskens EJM, Havekes LM, Kalmijn S, et al. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ 1994;309:1202-6.
8. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 1994;309:636-8.
9. Kurz A, Altland K, Lautenschlager N, et al. Apolipoprotein E type 4 allele and Alzheimer's disease: effect on age at onset and relative risk in different age groups. J Neurol 1996;243:452-6.
10. Murphy GM Jr, Taylor J, Kraemer HC, et al. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. Am J Psychiatry 1997;154:603-8.
11. Craft S, Teri L, Edland SD, et al. Accelerated decline in apolipoprotein E ∈4 homozygotes with Alzheimer's disease. Neurology 1998;51:149-53.
12. Verpillat P, Camuzat A, Hannequin D, et al. Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis. Eur J Hum Genet 2002;10:399-405.
13. Stevens M, van Duijn CM, de Knijff P, et al. Apolipoprotein E gene and sporadic frontal lobe dementia. Neurology 1997;48:1526-9.
14. Fabre SF, Forsell C, Viitanen M, et al. Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency but no tau gene mutations. Exp Neurol 2001;168:413-18.
15. Geschwind D, Karrim J, Nelson F, et al. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Ann Neurol 1998;44:134-8.
16. Pickering-Brown SM, Owen F, Isaacs A, et al. Apolipoprotein E epsilon4 has no effect on age at onset or duration of disease in cases of frontotemporal dementia with Pick- or microvascular-type histology. Exp Neurol 2000;163:452-6.
17. Rosso SM, van Swieten JC, Roks G, et al. Apolipoprotein E4 in the temporal variant of frontotemporal dementia. [Letter]. J Neurol Neurosurg Psychiatry 2002;72:820.
18. Slooter AJ, Tang MX, van Duijn CM, et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA 1997;277:818-21.
19. Chapman J, Wang N, Treves TA, et al. ACE, MTHR, Factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 1998;29:1401-4.
20. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-92.
21. Marder K, Maestre G, Cote L, et al. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology 1994;45:1330-1.
22. Harhangi BS, de Rijk MC, van Duijn CM, et al. APOE and the risk of PD with or without dementia in a population-based study. Neurology 2000;54:1272-6.